Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eiki Woo is active.

Publication


Featured researches published by Eiki Woo.


The Annals of Thoracic Surgery | 2011

Minimizing Cerebral Embolism in Resection of Distal Aortic Arch Aneurysm Through a Left Thoracotomy

Shigetoshi Mieno; Hideki Ozawa; Masahiro Daimon; Kan Hamori; Tomoyasu Sasaki; Eiki Woo; Takahiro Katsumata

BACKGROUND In order to reduce the risk of cerebral embolism during aortic replacement through a left thoracotomy, we performed ascending or arch aortic cannulation (AAC) as well as early extracorporeal perfusion (EEP) under deep hypothermic circulatory arrest (DHCA). In this study we examined the effectiveness of these modifications in preventing cerebral embolism after distal arch replacement. METHODS Between January 2006 and March 2010, 40 patients underwent distal arch replacement through a left thoracotomy, using 2 pieces of an artificial graft. In all patients, AAC, EEP, and the open technique for aortic anastomosis were performed under DHCA. The AAC resulted in the proximal aortic perfusion from the proximal site of the diseased aorta. The EEP was induced by aortic distal perfusion from the side branch of a distal graft. After completion of the proximal anastomosis under EEP and DHCA, anastomosis between the proximal and distal grafts was made during rewarming. Neurologic deficit in the brain and spinal cord, as well as early surgical results, were clinically evaluated. RESULTS There was no permanent neurologic deficit after the surgery in the operative survivors. No patient had a stroke (0%). Temporary paraplegia and paraparesis occurred in 1 and 2 patients, respectively (7.7%); all 3 patients were able to walk prior to their discharge from hospital. Mortality in this series was 5.0% (2 of 40 patients); the cause of death was rupture of an esophageal ulcer and cardiogenic shock possibly due to myocardial infarction. CONCLUSIONS The AAC and EEP, in addition to deep hypothermia and DHCA, minimized the risk of cerebral embolism after distal arch aortic replacement by the left lateral approach.


Current Vascular Pharmacology | 2017

Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416

Eiki Woo; Ryuji Kato; Hideki Imano; Yuji Fujiwara; Yoshio Ijiri; Yoshikatsu Okada; Takehiro Yamaguchi; Yasukatsu Izumi; Minoru Yoshiyama; Takahiro Katsumata; Tetsuya Hayashi

BACKGROUND Sugen5416 (semaxinib) is an inhibitor of the vascular endothelial growth factor (VEGF) receptor. A rat model of Pulmonary Arterial Hypertension (PAH), created with Sugen5416 and chronic hypoxia, is known to have similar histological findings to those of PAH patients. OBJECTIVE To evaluate the pathophysiological mechanisms of cardiac remodeling due to hypoxic stress with Sugen5416 in vivo. METHODS Male Sprague-Dawley rats were exposed to hypoxia (10 ± 1% O2) for 2 weeks after a single injection of Sugen5416 (SU-hypoxia group) or the vehicle (V-hypoxia group). RESULTS Hypoxia elevated right ventricular (RV) systolic pressure and caused RV remodeling on Day 14. By electron microscopy, metamorphosis of capillaries with endothelial cell occlusive degeneration was observed in the RV myocardium of the SU-hypoxia group from Day 3. After reoxygenation, progressive RV remodeling with extensive degeneration of cardiomyocytes was observed in the SUhypoxia group, associated with a significant increase of oxidative stress and TUNEL-positive cells in both RV and left ventricular myocardium on Day 84. The expression of VEGF mRNA in the RV myocardium was significantly suppressed in the SU-hypoxia group on Day 3, whereas delayed activation of VEGF/extracellular signal-regulated kinase (ERK) signaling pathway on Day 14 were observed. CONCLUSION Capillary degeneration and activation of VEGF/ERK signaling pathway might be crucial to accelerate the cardiac remodeling due to hypoxic stress with Sugen5416.


The Annals of Thoracic Surgery | 2007

Successful Surgical Treatment for Dilated Cardiomyopathy With Cardiac Sarcoidosis

Masahiro Daimon; Tomoyasu Sasaki; Eiki Woo; Hideki Ozawa; Tomoshige Morimoto; Takahiro Katsumata


Japanese Journal of Cardiovascular Surgery | 2011

Surgical Treatment for Kommerell Diverticulm

Shigetoshi Mieno; Hideki Ozawa; Masahiro Daimon; Tomoyasu Sasaki; Eiki Woo; Takahiro Katsumata


Japanese Journal of Cardiovascular Surgery | 2012

Two Cases of Pseudoaneurysms in Multiple Anastomotic Sites Occurring after the Original Bentall and Cabrol Procedure

Tomoyasu Sasaki; Hayato Konishi; Yoshikazu Motohashi; Hiroaki Uchida; Mari Kakita; Eiki Woo; Sachiko Kanki; Masahiro Daimon; Hideki Ozawa; Takahiro Katsumata


European Heart Journal | 2018

P2501Rivaroxaban combined with spironolactone attenuates cardiovascular remodeling due to hypoxia in pulmonary arterial hypertension

Tetsuya Hayashi; S Matsumoto; A Hosokawa; K Yamamoto; Atsuo Nomura; Eiki Woo; Hideki Imano; Ryuji Kato; Yoshio Ijiri; Takehiro Yamaguchi; Yasukatsu Izumi; Minoru Yoshiyama; Yoshikatsu Okada; Michio Asahi


Japanese Journal of Cardiovascular Surgery | 2015

Ruptured Coronary Aneurysm with a Congenital Coronary Arteriovenous Fistula

Sachiko Kanki; Mari Kakita; Eiki Woo; Tomoyasu Sasaki; Masahiro Daimon; Takahiro Katsumata


Journal of Cardiac Failure | 2014

VEGF Overexpression and Right Ventricular Remodeling in Rats Exposed to Chronic Hypoxia

Mika Matsui; Eiki Woo; Takahiro Katsumata; Takehiro Yamaguchi; Minoru Yoshiyama; Yasukatsu Izumi; Atsuo Nomura; Yuji Fujiwara; Ryuji Kato; Tetsuya Hayashi


Archive | 2013

Sarcoidosis Successful Surgical Treatment for Dilated Cardiomyopathy With Cardiac

Takahiro Katsumata; Masahiro Daimon; Tomoyasu Sasaki; Eiki Woo; Hideki Ozawa; Tomoshige Morimoto


Japanese Journal of Cardiovascular Surgery | 2013

Successful Repair of Tricuspid Valve Endocarditis in a Drug Abuser

Hiroaki Uchida; Hayato Konishi; Yoshikazu Motohashi; Mari Kakita; Eiki Woo; Tomoyasu Sasaki; Shigetoshi Mieno; Masahiro Daimon; Hideki Ozawa; Takahiro Katsumata

Collaboration


Dive into the Eiki Woo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ryuji Kato

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tetsuya Hayashi

Osaka University of Pharmaceutical Sciences

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge